Karus Therapeutics
Biotechnology, Life Science, Pharmaceutical
Founded in 2005-01-01
Chilworth, Hampshire, United Kingdom
For Profit
About Karus Therapeutics
Karus is an emerging pharmaceutical company whose R&D activities are focused on the design and development of innovative, molecular-targeted, small molecule drugs to treat immune/inflammatory disorders and cancer.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: 11 active products
Financial Information
- Estimated Revenue: $10M to $50M
- Total Funding: 14753207 USD
- Last Funding: None (Series B)
- Funding Status: Early Stage Venture
Technology Stack
Karus Therapeutics actively uses 11 products in their tech stack.
Market Presence
Industries: Biotechnology, Life Science, Pharmaceutical
Headquarters: Chilworth, Hampshire, United Kingdom